More recently, in an innovative approach, Chen et al. engineered a murine glioblastoma cell line to secrete IFNβ and GM-CSF, while removing sensitivity to IFNβ-induced cell death by deletion of Ifnar1, the IFNβ receptor [85]. The gene discussed is IFNB1; the disease is glioblastoma.